Using public gene expression datasets, we found that the TSC22D3 mRNA expression was lower in specific subgroups of human NAFLD patients presenting elevated LF scores63,64. This evidence concerns the gene TSC22D3 and metabolic dysfunction-associated steatotic liver disease.